mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
BRD-K85133207 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.4 |
mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.4 |
mRNA |
KIN001-266 |
GDSC1000 |
pan-cancer |
AAC |
0.032 |
0.4 |
mRNA |
ELCPK |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.4 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.4 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.4 |
mRNA |
NSC 74859 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.4 |
mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.4 |